Alternate: Neoadjuvant Endocrine Treatment In Er+/Her2- Breast Cancer

ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

Neoadjuvant Endocrine Therapy in Breast Cancer

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne

European Society for Medical Oncology (ESMO)

Treating ER+ breast cancer patients with endocrine therapy resistance

Optimizing adjuvant treatment in HR+/HER2- early breast cancer

Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer

Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Hormonal Therapy for Breast Cancer: We Teach You

Breast Cancer School for Patients

Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

SERDs for patients with ER+/HER2- breast cancer

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Evaluating the Role of Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

RxPONDER: chemotherapy and endocrine therapy in HR+/HER2- breast cancer

Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer

Optimizing Treatment Options for HER2+/ ER+ Breast Cancer using Models of Endocrine Resistance

Neoadjuvant hormonal treatment for luminal breast cancer: rationale, evidence and outcome

What's NEW in Breast Cancer Treatment in 2023 | Top Breast Cancer Docs Discuss Emerging Research

The Patient Story

Dr. Callahan on Endocrine Therapy in Patients With ER-Positive Breast Cancer

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT